- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT07939763
Effects of Video-Based Education on Symptom Management Self-Efficacy and Quality of Life in Women Receiving Chemotherapy for Breast Cancer
The Effect of a Video-Based Educational Intervention on Symptom Management Self-Efficacy and Quality of Life in Women With Breast Cancer Receiving Chemotherapy
This study is designed as a randomized controlled trial to evaluate the effect of a video-based educational intervention on symptom management self-efficacy and quality of life in women diagnosed with breast cancer who are receiving chemotherapy. The study will be conducted at the Day Chemotherapy Unit of Akdeniz University Hospital. The study sample will consist of female patients diagnosed with breast cancer who meet the inclusion criteria and consent to participate. Participants will be divided into two groups: an intervention group and a control group.
Обзор исследования
Статус
Условия
Вмешательство/лечение
Подробное описание
This study is designed as a randomized controlled trial to evaluate the impact of a video-based educational intervention on self-efficacy for symptom management and quality of life in women diagnosed with breast cancer who are undergoing chemotherapy. The study will be conducted at the Day Chemotherapy Unit of Akdeniz University Hospital. The study sample will consist of women diagnosed with breast cancer who meet the inclusion criteria and consent to participate. Participants will be assigned to either an intervention group or a control group. The sample size was calculated using the G*Power 3.1.9 software, determining that a minimum of 72 participants-36 in each group-are required. Accounting for potential attrition, the study is planned to include a total of 90 participants, with 45 in the intervention group and 45 in the control group. In addition to routine care, patients in the intervention group will receive support for symptom management through a video-based educational intervention over a period of 8 weeks. Patients in the control group will receive the standard routine care provided at the study site. Data will be collected at three time points: baseline (T0), an interim follow-up (T1), and a final post-test (T2). The primary outcomes of the study are the level of self-efficacy regarding chemotherapy symptom management and quality of life. Secondary outcomes include the usability of the video-based educational intervention and instances of unplanned healthcare utilization (such as emergency department visits or unplanned hospital readmissions). Data collection will involve the use of a "Patient Information Form," the "Chemotherapy Symptom Management Self-Efficacy Scale for Breast Cancer," the "Functional Assessment of Cancer Therapy - Breast (FACT-B)," the "System Usability Scale," and a "Healthcare Utilization and Readmission Form" developed by the researcher. Data obtained from the study will be analyzed using the SPSS software package. It is anticipated that the video-based educational intervention will increase self-efficacy in symptom management among women diagnosed with breast cancer, improve their quality of life, and reduce the utilization of healthcare services, such as emergency department visits and hospital readmissions.
Тип исследования
Регистрация (Оцененный)
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
- Имя: Ümmühan Duman
- Номер телефона: 02422450000/3314
- Электронная почта: ummuhan.duman@antalya.edu.tr
Места учебы
-
-
Antalya
-
Antalya, Antalya, Турция (Туркие), 07190
- Antalya Bilim University
-
Контакт:
- Ümmühan Duman
- Номер телефона: 02422450000/3314
- Электронная почта: ummuhan.duman@antalya.edu.tr
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
- Ребенок
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Being 18 years of age or older,
- Being able to read and write in Turkish,
- Having no barriers to written or verbal communication,
- Being newly diagnosed with breast cancer and being aware of the diagnosis,
- Having received at least two cycles of chemotherapy,
- Having access to an internet-enabled digital device (e.g., smartphone), either personally owned or shared with family members, and being able to use it actively,
- Having an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2.
Exclusion Criteria:
- Patients who do not agree to participate in the study,
- Patients participating in another study related to symptom management,
- Patients with a history of diagnosed psychiatric disorders,
- Patients with an Eastern Cooperative Oncology Group (ECOG) Performance Status of 3 or higher.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Поддерживающая терапия
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Двойной
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: INTERVENTION GROUP
In addition to routine care, patients in the intervention group will receive symptom management support over an 8-week period through a video-based educational intervention. |
Participants in the intervention group will receive an 8-week video-based educational intervention in addition to standard care. The web-based platform will provide evidence-based educational videos on chemotherapy-related symptoms and symptom management. Participants will be directed to symptom-specific videos through a rule-based algorithm based on their self-reported symptoms. They will be asked to access the platform at least three times per week and will receive reminder messages twice weekly. Platform usage will be monitored, and post-intervention assessments will be conducted after the 8-week intervention. |
|
Без вмешательства: CONTROL GROUP
Patients in the control group will receive the routine care provided at the center where the study is being conducted. |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Self-Efficacy Scale for Breast Cancer Related to Chemotherapy (SMSES-BC)
Временное ограничение: Baseline (T0), Week 4 (T1), and Week 8 (T2).
|
Symptom management self-efficacy will be assessed using the Symptom Management Self-Efficacy Scale for Breast Cancer Related to Chemotherapy (SMSES-BC). Changes in self-efficacy scores will be evaluated across three assessment points. |
Baseline (T0), Week 4 (T1), and Week 8 (T2).
|
|
Functional Assessment of Cancer Therapy-Breast (FACT-B)
Временное ограничение: Baseline (T0), Week 4 (T1), and Week 8 (T2).
|
Quality of life will be assessed using the Functional Assessment of Cancer Therapy-Breast (FACT-B). Changes in quality-of-life scores will be evaluated across three assessment points. |
Baseline (T0), Week 4 (T1), and Week 8 (T2).
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
System Usability Scale (SUS)
Временное ограничение: At the end of the intervention (T2).
|
System usability will be assessed in the intervention group using the System Usability Scale (SUS) to evaluate participants' perceptions of the video-based educational platform. |
At the end of the intervention (T2).
|
|
Hospital Readmissions
Временное ограничение: Week 8 (T2), covering the previous 8 weeks.
|
Hospital readmissions will be assessed using a researcher-developed healthcare utilization form, including the occurrence, frequency, and duration of hospital readmissions during the 8-week study period. |
Week 8 (T2), covering the previous 8 weeks.
|
|
Emergency Department Visits
Временное ограничение: Week 8 (T2), covering the previous 8 weeks.
|
The number and reasons for emergency department visits during the 8-week study period will be assessed using a researcher-developed healthcare utilization form. |
Week 8 (T2), covering the previous 8 weeks.
|
|
Unplanned Healthcare Visits
Временное ограничение: Week 8 (T2), covering the previous 8 weeks.
|
The frequency and reasons for unplanned outpatient clinic visits and other healthcare facility visits will be assessed using a researcher-developed healthcare utilization form. |
Week 8 (T2), covering the previous 8 weeks.
|
|
Treatment-Related Economic Burden
Временное ограничение: Week 8 (T2), covering the previous 8 weeks.
|
Treatment-related economic burden will be assessed using a researcher-developed form to evaluate the financial burden associated with healthcare utilization during the study period. |
Week 8 (T2), covering the previous 8 weeks.
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Ümmühan Duman, Antalya Bilim University- ummuhan.duman@antalya.edu.tr
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Первичное завершение (Оцененный)
Завершение исследования (Оцененный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- ABU_HEM_ÜD_2026
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .